Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer
Open Access
- 10 June 2003
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 88 (12), 1859-1865
- https://doi.org/10.1038/sj.bjc.6600995
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminary safety resultsSeminars in Oncology, 2001
- A review of 560 Hickman catheter insertionsAnaesthesia, 1996
- The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancerAnnals of Oncology, 1996
- Effective Surgical Adjuvant Therapy for High-Risk Rectal CarcinomaNew England Journal of Medicine, 1991
- Adjuvant Therapy for Patients With Colon and Rectal CancerJAMA, 1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011JNCI Journal of the National Cancer Institute, 1988
- Survival after Postoperative Combination Treatment of Rectal CancerNew England Journal of Medicine, 1986
- Prolongation of the Disease-Free Interval in Surgically Treated Rectal CarcinomaNew England Journal of Medicine, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958